日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma

人类细胞外囊泡蛋白质组学分析揭示结肠腺癌的诊断生物标志物

Seo, Yura; Han, Yoon Dae; Bojmar, Linda; Kim, Kyung-A; Seo, Yurin; Kim, Taeyul K; Lee, Suho; Kim, Yeleem; Choi, Hye Bin; Lim, Yujin H; Kim, Chae Hyun; Sandberg, Alexander; Fan, Chuanwen; Lauritzen, Pernille; Molina, Henrik; Peralta, Christopher; Geri, Jacob B; Burdette, Colin; Han, Dai Hoon; Gee, Heon Yung; Lee, Insuk; Shin, Jeon-Soo; Kim, Hyunwook; Li, Leon; Tobias, Gabriel C; Wortzel, Inbal; Shin, Sang Joon; Jung, Hyo-Il; Lee, Min Goo; Paik, Soonmyung; Schwartz, Robert E; Ahn, Joong Bae; Lyden, David; Kim, Han Sang

PHI-501, a dual inhibitor of RAF and DDR1/2, overcomes MAPK drug resistance in Melanoma

PHI-501 是一种 RAF 和 DDR1/2 双重抑制剂,可克服黑色素瘤中的 MAPK 药物耐药性。

Kim, Sue Min; Cho, Sungmin; Sung, Gi-Jun; Nam, Ky-Youb; Yoon, JeongHyeok; Sim, Taebo; Ahn, Joong Bae; Shin, Sang Joon

Efficacy and Safety of Ifosfamide and Mesna in Metastatic Castration-Resistant Prostate Cancer after Taxane-Based Chemotherapy and Novel Hormonal Therapy Failure

异环磷酰胺和美司钠治疗紫杉烷类化疗和新型激素疗法失败后的转移性去势抵抗性前列腺癌的疗效和安全性

Kim, Chang Gon; Ko, Yeo Gyeong; Yoon, Jongjin; Lee, Chung; Beom, Seung Hoon; Choi, Young-Deuk; Han, Woong Kyu; Ham, Won Sik; Han, Hyunho; Lee, Jongsoo; Heo, Ji Eun; Kim, Daeseong; Baek, Eun Sil; Kim, Sangwoo; Jung, Minsun; Shin, Sang Joon

A Multicenter Phase II Study of Modified FOLFIRINOX for First-Line Treatment for Advanced Urachal Cancer (ULTIMA; KCSG GU20-03)

一项多中心 II 期研究,评估改良 FOLFIRINOX 方案一线治疗晚期脐尿管癌的疗效(ULTIMA;KCSG GU20-03)

Park, Inkeun; Lee, Jae Lyun; Yoon, Shinkyo; Shin, Sang Joon; Shin, Seong-Hoon; Kim, Jung Hoon; Park, Kwonoh; Lee, Hyo Jin

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma

EV-302/KEYNOTE-A39 泛亚洲亚组分析:一项评估恩福妥单抗和帕博利珠单抗治疗未经治疗的晚期尿路上皮癌患者的 3 期研究

Kikuchi, Eiji; Van der Heijden, Michiel S; Valderrama, Begoña P; Gupta, Shilpa; Bedke, Jens; Shin, Sang Joon; Li, Jian-Ri; Guo, Jun; Danchaivijitr, Pongwut; Kanesvaran, Ravindran; Park, Se Hoon; Su, Wen-Pin; Kandori, Shuya; Bae, Woo Kyun; Wong, Alvin; Gorla, Seema; Bavle, Abhishek; Yu, Xuesong; Lu, Yi-Tsung; Powles, Thomas

Continuous multimodal data supply chain and expandable clinical decision support for oncology

肿瘤学的连续多模态数据供应链和可扩展的临床决策支持

Chang, Jee Suk; Kim, Hyunwook; Baek, Eun Sil; Choi, Jeong Eun; Lim, Joon Seok; Kim, Jin Sung; Shin, Sang Joon

Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial

Nemvaleukin alfa 单药治疗晚期黑色素瘤和肾细胞癌患者:来自 ARTISTRY-1 1/2 期非随机试验的结果

Calvo, Emiliano; Boni, Valentina; Dumas, Olivier; Shin, Sang Joon; Rosen, Seth D; Chaudhry, Arvind; Debruyne, Philip R; He, Xiaomin; Vaishampayan, Ulka N; McDermott, David F

Targeting iron regulatory protein 2 (IRP2) to disrupt iron metabolism enhances radiosensitivity through mitochondrial dysfunction in breast cancer cells.

通过靶向铁调节蛋白 2 (IRP2) 来破坏铁代谢,从而通过线粒体功能障碍增强乳腺癌细胞的放射敏感性

Jeong Ye Yeong, Hwang Jieon, Park Areum, Cho Sungmin, Cho Inyoung, Won Soseul, Shin You Me, Kim Sung Eun, Maeng Chan Hoon, Yang Jaemoon, Ku Minhee, Lee Hyuk, Shin Sang Joon

Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011

帕博利珠单抗治疗晚期尿路上皮癌患者(可能不适合接受含铂化疗)的疗效和安全性:KEYNOTE-052 和 LEAP-011 研究的事后分析

O'Donnell, Peter H; Loriot, Yohann; Csoszi, Tibor; Matsubara, Nobuaki; Shin, Sang Joon; Park, Se Hoon; Atduev, Vagif; Gumus, Mahmut; Karaca, Saziye Burcak; Grivas, Petros; de Wit, Ronald; Castellano, Daniel E; Powles, Thomas; Vuky, Jacqueline; Zhao, Yujie; O'Hara, Karen; Okpara, Chinyere E; Franco, Sonia; Homet Moreno, Blanca; Żołnierek, Jakub; Siefker-Radtke, Arlene O

Discovery of a selective dual-specificity tyrosine phosphorylation-regulated kinase 1B inhibitor with anti-adipogenic and anti-diabetic activities.

发现一种具有抗脂肪生成和抗糖尿病活性的选择性双特异性酪氨酸磷酸化调节激酶 1B 抑制剂

Kang Sein, Na Yoon-Ju, Choi Kyoung Jin, Jung Won Hoon, Park Areum, Im Jeonghui, Park Sung Bum, Koh Byumseok, Lee Joo-Youn, Hoe Kwang-Lae, Kim Heung Jae, Shin Sang Joon, Lee Hyuk, Kim Ki Young